Skip to main content

Table 2 Outcome of patients treated with BLICs or carbapenems

From: Comparison of therapy with β-lactam/β-lactamase inhibitor combinations or carbapenems for bacteraemia of nonurinary source caused by ESBL-producing Escherichia coli or Klebsiella pneumoniae

Outcomes

BLICs

Carbapenems

Univariate analysis

Multivariate analysis

N (%)

Adjusted N (%)

N (%)

Adjusted N (%)

P

Adjusted P

HR (95%CI), P

Adjusted HR (95%CI), P

14-day treatment failure

25 (21.9)

13 (20.6)

17 (25.8)

7 (16.3)

0.970

0.429

1.61 (0.74–3.49), 0.230

2.19 (0.81–5.90), 0.122

30-day mortality

13 (11.4)

7 (11.1)

13 (19.7)

5 (11.6)

0.289

0.926

1.57 (0.62–4.01), 0.345

1.68 (0.48–5.93), 0.420